M

Milestone Pharmaceuticals
D

MIST

0.90310
USD
-0.02
(-2.05%)
مفتوح الان
حجم التداول
4,201
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
112,434,126
المقالات
المزيد

العنوان: Milestone Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.